Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
2,111
datasets available to search
ShareScore release 0.9.0
Dataset results
2,111 results for “bevacizumab”
Bioequivalence Study Bevacizumab Biosimilar (BEVZ92) Versus Bevacizumab (AVASTIN®) in First-line Treatment mCRC Patients
ClinicalTrials.gov study NCT02069704. IPD Sharing: Not stated. Countries: 5. Publications: 1.
Capecitabine, Cetuximab, Oxaliplatin, and Bevacizumab in Treating Patients With Metastatic or Recurrent Colorectal Cancer That Cannot Be Removed By Surgery
ClinicalTrials.gov study NCT00290615. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Paclitaxel and Carboplatin With or Without Bevacizumab in Treating Patients With Stage II, Stage III, or Stage IV Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer
ClinicalTrials.gov study NCT01167712. IPD Sharing: Not stated. Countries: 3. Publications: 2.
Bevacizumab for Treatment of Recurrent Respiratory Papillomatosis (RRP)
ClinicalTrials.gov study NCT01020747. IPD Sharing: Not stated. Countries: 1. Publications: 22.
QL1706 Plus Chemotherapy±Bevacizumab for the First-Line Treatment of Persistent, Recurrent or Metastatic Cervical Cancer
ClinicalTrials.gov study NCT05446883. IPD Sharing: NO. Countries: 1. Publications: 1.
Study of Enzastaurin With 5-Fluorouracil/Leucovorin (5-FU/LV) Plus Bevacizumab as Maintenance Regimen Following First Line Therapy for Metastatic Colon Cancer
ClinicalTrials.gov study NCT00612586. IPD Sharing: Not stated. Countries: 6. Publications: 1.
A Study of Atezolizumab Versus Placebo in Combination With Paclitaxel, Carboplatin, and Bevacizumab in Participants With Newly-Diagnosed Stage III or Stage IV Ovarian, Fallopian Tube, or Primary Perit
ClinicalTrials.gov study NCT03038100. IPD Sharing: Not stated. Countries: 22. Publications: 4.
Bevacizumab With or Without Radiation Therapy in Treating Patients With Recurrent Glioblastoma
ClinicalTrials.gov study NCT01730950. IPD Sharing: Not stated. Countries: 1. Publications: 1.
CAPOX, Bevacizumab and Trastuzumab for Patients With HER2-Positive Metastatic Esophagogastric Cancer
ClinicalTrials.gov study NCT01191697. IPD Sharing: Not stated. Countries: 1. Publications: 25.
Efficacy and Safety Study of ABP 215 Compared With Bevacizumab in Patients With Advanced Non-Small Cell Lung Cancer
ClinicalTrials.gov study NCT01966003. IPD Sharing: Not stated. Countries: 3. Publications: 1.
Ph II SAHA and Bevacizumab for Recurrent Malignant Glioma Patients
ClinicalTrials.gov study NCT01738646. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Sorafenib and Bevacizumab to Treat Ovarian, Fallopian and Peritoneal Cancer
ClinicalTrials.gov study NCT00436215. IPD Sharing: NO. Countries: 1. Publications: 4.
HAIC With Oxaliplatin, 5-FU and Bevacizumab Plus Intravenous Toripalimab for Advanced BTC
ClinicalTrials.gov study NCT04217954. IPD Sharing: NO. Countries: 1. Publications: 9.
Temozolomide and Radiation Therapy With or Without Bevacizumab in Treating Patients With Newly Diagnosed Glioblastoma
ClinicalTrials.gov study NCT00884741. IPD Sharing: Not stated. Countries: 3. Publications: 1.
Phase (Ph) II Bevacizumab + Erlotinib for Patients (Pts) With Recurrent Malignant Glioma (MG)
ClinicalTrials.gov study NCT00671970. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Capecitabine and Bevacizumab With or Without Atezolizumab in Treating Patients With Refractory Metastatic Colorectal Cancer
ClinicalTrials.gov study NCT02873195. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Bevacizumab, Autologous Tumor/DC Vaccine, IL-2 and IFNα-2b in Metastatic Renal Cell Carcinoma (RCC) Patients
ClinicalTrials.gov study NCT00913913. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Docetaxel and Prednisone With or Without Bevacizumab in Treating Patients With Prostate Cancer That Did Not Respond to Hormone Therapy
ClinicalTrials.gov study NCT00110214. IPD Sharing: Not stated. Countries: 1. Publications: 3.
Pembrolizumab, Capecitabine, and Bevacizumab for Treating Colorectal Cancer
ClinicalTrials.gov study NCT03396926. IPD Sharing: NO. Countries: 1. Publications: 0.
A Study of Bevacizumab in Combination With Chemotherapy for Treatment of Osteosarcoma
ClinicalTrials.gov study NCT00667342. IPD Sharing: Not stated. Countries: 1. Publications: 1.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.